George Kulik
Affiliations: |
Google:
"George Kulik"Mean distance: 39813
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Alaskar A, Abdulraqeb Ali A, Hassan S, et al. (2022) Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells. The Prostate |
Ali A, Kulik G. (2021) Signaling Pathways That Control Apoptosis in Prostate Cancer. Cancers. 13 |
Hassan MS, Pullikuth A, Nelson KC, et al. (2020) Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. Molecular Cancer Research : McR |
Kulik G. (2019) ADRB2-Targeting Therapies for Prostate Cancer. Cancers. 11 |
Cantrell W, Huang Y, Menchaca AA, et al. (2018) Synthesis and PI3 Kinase Inhibition Activity of a Wortmannin-Leucine Derivative. Molecules (Basel, Switzerland). 23 |
Wright EW, Nelson RA, Karpova Y, et al. (2018) Synthesis and PI3 Kinase Inhibition Activity of Some Novel Trisubstituted Morpholinopyrimidines. Molecules (Basel, Switzerland). 23 |
Nelson RA, Schronce T, Huang Y, et al. (2018) Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines. Molecules (Basel, Switzerland). 23 |
Sastry KS, Chouchane AI, Wang E, et al. (2017) Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling. Cell Death & Disease. 8: e2844 |
Zhang Q, Wan M, Shi J, et al. (2016) Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation. Journal of Molecular Cell Biology |
Kulik G. (2015) Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network. Asian Journal of Andrology. 17: 471-4 |